Esomeprazole Sodium
NDC Package 55150-184-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Esomeprazole Sodium is a . Marketed by Auromedics Pharma Llc, this product is identified by NDC 55150-184 and is authorized under FDA application ANDA204657.

Identification & Billing

NDC Package Code
55150-184-05
Package Description
10 VIAL in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product Code
55150-184
11-Digit Billing Format
55150018405

Clinical Specifications

Proprietary Name
Esomeprazole Sodium
Dosage Form
-

Regulatory & Marketing

Labeler Name
Auromedics Pharma Llc
FDA Application #
ANDA204657
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-10-2016
End Marketing Date
12-04-2019
Listing Expiration
12-04-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55150-184-05 identifies a specific commercial package of 10 vial in 1 carton / 1 injection, powder, lyophilized, for solution in 1 vial of Esomeprazole Sodium, labeled by Auromedics Pharma Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Auromedics Pharma Llc on August 10, 2016. The current certification is valid through December 04, 2019.

How is this Auromedics Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55150018405. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55150-184-05
11-Digit CMS (5-4-2)
55150-0184-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.